Significant roles of neuroinflammation in Parkinson's disease: therapeutic targets for PD prevention
- PMID: 30830660
- DOI: 10.1007/s12272-019-01133-0
Significant roles of neuroinflammation in Parkinson's disease: therapeutic targets for PD prevention
Abstract
Glial cells outnumber neurons in the brain and play important roles in the neuroinflammation that accompanies brain damage in neurodegenerative diseases. In Parkinson's disease (PD), dopaminergic neuronal loss is accompanied by inflammatory changes in microglia, astrocytes, innate immune cells, and infiltrating peripheral immune cells. Neuroinflammation is probably a fundamental immune response to protect neurons from harm and compensate for neuronal damage, but at the same time, its neurotoxic effects exacerbate neuron damage. Furthermore, neuroinflammatory response is regulated by immune cells, such as microglia, astrocytes, and peripheral immune cells, and by cytokines and chemokines. Accordingly, it is crucial that we understand how such immune cells in the brain regulate neuroinflammatory responses in PD pathology. This review describes the roles played by glia-mediated neuroinflammation in PD, both good and bad, and the therapeutic strategies used to treat PD.
Keywords: A1 astrocyte; A2 astrocyte; Glia; Microglia; Neuroinflammation; Parkinson’s disease.
Similar articles
-
Glial reactions in Parkinson's disease.Mov Disord. 2008 Mar 15;23(4):474-83. doi: 10.1002/mds.21751. Mov Disord. 2008. PMID: 18044695 Review.
-
Intranigral Administration of β-Sitosterol-β-D-Glucoside Elicits Neurotoxic A1 Astrocyte Reactivity and Chronic Neuroinflammation in the Rat Substantia Nigra.J Immunol Res. 2020 Nov 16;2020:5907591. doi: 10.1155/2020/5907591. eCollection 2020. J Immunol Res. 2020. PMID: 33282962 Free PMC article.
-
Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.Curr Pharm Des. 2007;13(18):1925-8. doi: 10.2174/138161207780858429. Curr Pharm Des. 2007. PMID: 17584117 Review.
-
Drugs to Treat Neuroinflammation in Neurodegenerative Disorders.Curr Med Chem. 2024;31(14):1818-1829. doi: 10.2174/0929867330666230403125140. Curr Med Chem. 2024. PMID: 37013428 Review.
-
Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase.Nutr Neurosci. 2018 Jun;21(5):341-351. doi: 10.1080/1028415X.2017.1290928. Epub 2017 Feb 21. Nutr Neurosci. 2018. PMID: 28221817
Cited by
-
TREM-1 mediates interaction between substantia nigra microglia and peripheral neutrophils.Neural Regen Res. 2024 Jun 1;19(6):1375-1384. doi: 10.4103/1673-5374.385843. Epub 2023 Sep 22. Neural Regen Res. 2024. PMID: 37905888 Free PMC article.
-
Neurodegenerative Diseases: Unraveling the Heterogeneity of Astrocytes.Cells. 2024 May 27;13(11):921. doi: 10.3390/cells13110921. Cells. 2024. PMID: 38891053 Free PMC article. Review.
-
The modifying effect of mutant LRRK2 on mutant GBA1-associated Parkinson disease.Hum Mol Genet. 2025 Jul 3;34(14):1184-1203. doi: 10.1093/hmg/ddaf062. Hum Mol Genet. 2025. PMID: 40315377 Free PMC article.
-
The synergetic effect of edaravone and scutellarin in the MPP(+)-induced cell model of Parkinson's disease.Histol Histopathol. 2025 Sep;40(9):1457-1466. doi: 10.14670/HH-18-874. Epub 2025 Jan 16. Histol Histopathol. 2025. PMID: 39851081
-
Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson's disease.Front Pharmacol. 2022 Sep 12;13:977521. doi: 10.3389/fphar.2022.977521. eCollection 2022. Front Pharmacol. 2022. PMID: 36172194 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials